Cancer-killing living drug is made safer with a simple off-switch

 

You might have heard of CAR-T: a cellular immunotherapy extracts a patient’s own immune cells, amps up their tumor-hunting prowess using gene therapy, and infuses the super-soldiers back into the patient to pursue and rip their targets to shreds—literally. In Late 2017, the US’ FDA approved the CAR-T therapy was approved for leukemia and lymphoma, deadly childhood cancers generally unmanageable with classic chemotherapy or radiation.

When it comes to battling cancer, our most powerful weapon is also our most dangerous.

Read the Article